Opko Health Inc

Financials

営業活動によるキャッシュフロー 39.48 M38.34 M-95.19 M-28.2 M-183.49 M-178.54 M -178.54 M 投資活動によるキャッシュフロー -18.33 M35.95 M91.04 M-18.2 M352.21 M230.3 M 230.3 M 財務活動によるキャッシュフロー -35.08 M-10.35 M22.97 M-11.3 M184.17 M-118.06 M -118.06 M フリーキャッシュフロー 5.79 M6.18 M-119.77 M-44.47 M-208.5 M-190.82 M -190.82 M

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

OPK

Financials

Opko Health Inc

ニュース

OPKO Health: The Waiting Game Continues (NASDAQ:OPK)

Here's Why You Should Hold OPK Stock in Your Portfolio for Now

OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

OPKO Health, Inc. (OPK) Q4 2025 Earnings Call Transcript

Compared to Estimates, OPKO Health (OPK) Q4 Earnings: A Look at Key Metrics

OPKO Health (OPK) Reports Q4 Loss, Tops Revenue Estimates

【決算速報】オプコ・ヘルス、売上高は予想を上回り、利益は予想を上回る結果に

Opko Health earnings beat by $0.03, revenue topped estimates

Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?

H.C. ウェインライトがOpko Healthの株式評価を「買い」で再確認

Opko Health stock rating reiterated at Buy by H.C. Wainwright

OPKOとEnteraが副甲状腺機能低下症治療のための経口PTH開発で提携拡大